NK-012

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameNK-012
Drug Alias NamePolymeric micelle camptothecin analogue - Nippon KayakuPEGylated prodrug of SN-38NK-012
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsSolid tumoursSmall Cell Lung CarcinomaColorectal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Kayaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Kayaku Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursSmall Cell Lung CarcinomaColorectal Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A